New protein synthesis has been implicated as necessary for long-lasting changes in neuronal function. Behavioural sensitization to a single exposure to addictive drugs is a form of neuroplasticity, but little is known about the importance of new protein synthesis in the underlying mechanism. This study was designed to investigate the effects of the transcription inhibitor actinomycin D (AD) and the protein synthesis inhibitor cycloheximide (CHX) on induction of behavioural sensitization to a single morphine exposure in mice. In combination with behavioural experiments, changes in gene and protein expression in the mouse nucleus accumbens (NAc) were analysed by RT-PCR array and Western blot respectively. Behavioural sensitization was evident in mice pretreated only once with morphine at the doses of 20 and 40 mg/kg, but not 5 and 10 mg/kg. Mice pretreated with morphine (20 mg/kg) and challenged with a lower dose (5 mg/kg) after a period of 4-21 d washout showed sensitized locomotion. At the doses that did not affect locomotion in mice, AD or CHX significantly suppressed hyperactivity induced by acute treatment, but not challenge with morphine, and blocked induction of behavioural sensitization to a single morphine exposure in a dose-related manner. The results from RT-PCR array and Western blot indicated that the changes of Hsp70 expression in the NAc of mice were associated with behavioural sensitization induced by a single morphine exposure. Together, these findings suggest that induction of behavioural sensitization to a single morphine exposure requires new protein synthesis, potentially involving Hsp70 expression in the NAc of mice.
Introduction
Drug-associated or drug-dependent behavioural plasticity is thought to be an important mechanism underlying drug addiction. Behavioural sensitization is a long-lasting form of neuroplasticity that has been associated with incentive-salience that contributes to the compulsive drug-seeking and drug-taking that characterize addiction (Koob, 2008 ; Robinson & Berridge, 2000 ; Thomas et al. 2008 ; Vezina, 2007) . Interestingly, even a single exposure to morphine, amphetamine, cocaine, and even apomorphine seems able to produce long-lasting behavioural changes in rats (Bloise et al. 2007 ; Kalivas & Alesdatter, 1993 ; Robinson et al. 1982 ; Vanderschuren et al. 1999 Vanderschuren et al. , 2001 . Recently, Kim et al. (2004) have provided direct evidence for the relationship of behavioural sensitization induced by a single cocaine administration to the rewarding effects of abused drugs. Therefore, behavioural sensitization induced by a single exposure to addicting drugs has been proposed to contribute reward and motivation associated with subsequent drug dependence.
The involvement of learning and memory processes in neuroplasticity associated with drug addiction has been confirmed (Nestler, 2001a, b) . Memory and addiction share some neural circuits and molecular mechanisms (Kelley, 2004 ; Nestler, 2002) . Evidence has revealed the existence of de-novo protein synthesis during acquisition, consolidation and expression in learning and memory events (Kandel, 2001 ). Given the above, it would be consistent to hypothesize that behavioural sensitization to a single morphine exposure may involve the process of de-novo protein synthesis. However, this possibility has not been systematically investigated to date.
Behavioural sensitization is associated with changes in neural circuits that consist of the prefrontal cortex (PFC), ventral tegmental area (VTA), nucleus accumbens (NAc), hippocampus, and amygdala (Cador et al. 1995 ; Pierce & Kalivas, 1997 ; Vanderschuren & Kalivas, 2000) . The NAc is a critical component of the mesocorticolimbic system and plays a central role in mediating the reinforcing and behavioural sensitizing effects of addicting drugs. Anatomically, this nucleus receives dopaminergic projections from the VTA and glutamatergic projections from the PFC, amygdala, and hippocampus. Functionally, the NAc integrates excitatory and inhibitory signal inputs from limbic and cortical regions to regulate rewarding and aversive states (Carlezon & Thomas, 2009 ). Vanderschuren et al. (2001) reported that a single morphine injection can increase electrically evoked release of dopamine and acetylcholine from the slices of NAc in rats. Similarly, locomotor sensitization has been linked to drug-induced plasticity onto medium spiny neurons in the accumbens shell (Thomas et al. 2001) . Therefore, we directed molecular studies in relation to morphine sensitization to the NAc. cAMP-and/or Ca 2+ -signalling pathways in the central nervous system (CNS) are involved in morphine-induced behavioural sensitization (Biala & Weglinska, 2004 ; Vigano et al. 2003 ; Walters & Blendy, 2001 ; Yoshimura et al. 2000 ; Zhang et al. 2003) . Therefore, our study focused on the expression of genes in cAMP-and Ca 2+ -related signal transduction mechanisms in the NAc of morphine-sensitized mice. The RT-PCR array analysis system with selected genes relevant to cAMP/Ca 2+ signalling pathways can provide insights into the nature of behavioural plasticity associated with morphine sensitization. Accordingly, the study of the functional consequences of cellular and molecular signalling cascades in response to morphine treatment is essential to improve our understanding of the mechanisms underlying behavioural sensitization induced by a single morphine exposure.
Materials and methods

Animals
Male Kunming outbred mice (Shang et al. 2009 ), initially weighing between 18 and 22 g, were obtained from the Department of Laboratory Animal Science, Peking University Health Science Center. The animals were housed (n=4 per cage) in a colony room with controlled ambient temperature (22¡1 xC), humidity (50¡10 %), and a 12-h light/dark cycle (lights on 08:00 hours). Food and water were available ad libitum. All mice were habituated to the housing conditions for 3-4 d before experiments and each mouse was used only for one experiment. This study was conducted according to the NIH Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23, revised 1996) . The experimental procedures were approved by the local Committee of Beijing on Animal Care and Use.
Drugs
Morphine hydrochloride was obtained from Qinghai Pharmaceutical Manufactory (China). Actinomycin D (AD) and cycloheximide (CHX) were purchased from Sigma Chemical Co. (St Louis, USA). All drugs were dissolved in 0.9 % saline immediately before each experiment and were administered intraperitoneally (i.p.) in a volume of 0.1 ml/10 g.
Treatment paradigm and locomotor activity determination
In our laboratory, the standard protocol on morphineinduced locomotor sensitization consists of seven daily injections with 10 mg/kg morphine (Li et al. 2004a) . To determine sensitization to a single morphine exposure, we pretreated mice with 5, 10, 20 or 40 mg/kg morphine and locomotor activity was measured. Mice were then challenged with morphine (5 mg/kg i.p.) after 1, 2, 3, 4, 7, 14 or 21 drug-free days and locomotor activity was again measured. All mice were challenged only once. AD (6, 12 mg/kg i.p.) or CHX (1, 2 mg/kg i.p.) were used to investigate the effects of the transcription and protein synthesis inhibitors on hyperactivity and locomotor sensitization induced by a single morphine injection. Locomotor activity was determined in four identical boxes (25r25r45 cm) using DigBehv spontaneous activity monitors (DigBehv-LG, Shanghai Jiliang Software Technology Co. Ltd, China). Mice were placed into the test boxes to monitor locomotor activity at 5-min intervals for 60 min immediately after injection of morphine or saline. Horizontal locomotor activity was recorded with a video camera positioned above the cage and analysed with the DigBehv software (Version 2.0, Jiliang, China).
Brain tissue extraction
On day 8 (challenge test), all mice were decapitated 30 min after injection of morphine (5 mg/kg) or saline and the whole brain was rapidly dissected. According to the mouse brain atlas of Paxinos & Franklin (2001) , coronal slices (2-mm thick) containing the NAc from bilateral dissection were prepared using a mouse brain mould (McCormick Scientific, USA) on ice for RT-PCR array analysis and Western blot. Subsequently, the NAc was quickly removed, frozen immediately with liquid nitrogen and then stored at x80 xC until processed.
RT-PCR array and analysis
A total of 100 mice were used for RT-PCR array analysis and randomly divided into five groups : Sal+Sal+Sal group (control group) ; Sal+Sal+Mor 5 mg/kg group ; Sal+Mor 20 mg/kg+Mor 5 mg/kg group ; AD 12 mg/kg+Mor 20 mg/kg+Mor 5 mg/kg group ; and CHX 2 mg/kg+Mor 20 mg/kg+Mor 5 mg/kg group. Figure 7 a shows the experimental procedure in detail. For each group, samples from 20 mice (bilateral NAc) were pooled so that sufficient RNA was available to perform RT-PCR array analysis. Total RNA was isolated using Trizol reagent (Invitrogen, USA). The quantity and quality of total RNA were assessed by UV absorbance using NanoDrop 1 ND-1000 (Agilent Technologies, USA) according to the A 260 /A 280 ratio. Ratio values obtained were in the range of 1.8-2.1. RNA integrity was confirmed by agarose gel electrophoresis. After total RNA were extracted, the first-strand cDNAs were synthesized from 1.5 mg total RNA using a mixture of 500 ng oligo dT and 10 mM dNTP mix. After centrifugation, an additional 200 U Superscript III Reverse Transcriptase (Invitrogen), 0.1 m DTT and 40 U RNase inhibitor were added to mixed 20 ml reaction. Then the relative expression level of each gene was calculated using the DDC t method, first normalizing the gene expression levels to the expression of the five housekeeping genes (Gusb, Hprt1, Hsp90ab1, Gapdh, Actb), then comparing the normalized data between different groups, and the relative expression level of each gene was expressed as a percent change.
Western blot
Tissue samples were homogenized in RIPA lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 % NP-40, 0.1 % SDS] and cleared by centrifugation (12 000 g, 4 xC for 10 min). Protein concentration in the supernatant was determined using the BCA protein assay kit (Applygen Technologies Inc., China). Samples mixed with loading buffer (50 mM Tris-HCl, 2 % SDS, 2 % b-mercaptoethanol, 8 % glycerol, and 0.1 % Bromophenol Blue) were heated at 100 xC for 10 min and resolved by SDS-PAGE on 10 % polyacrylamide gels. After the gel electrophoresis, proteins were electrophoretically transferred to nitrocellulose membranes. Non-specific antibody binding sites were blocked by washing with Tris-buffered saline (TBS) buffer containing 5 % milk for 1 h. Subsequently, the blots were incubated with mouse anti-Hsp70 monoclonal antibody (1 : 1000 dilution ; R&D, USA) overnight at 4 xC and then the secondary antibody (HRP-conjugated goat anti-mouse IgG ; 1 : 2000 dilution) for 1 h at room temperature. The blots were developed using the chemiluminescent detection method (Applygen Technologies Inc.). We quantified the content of the Hsp70 protein presented in blots by densitometry using a Gel Doc 2000 densitometer (Bio-Rad, USA) and normalized to signals of b-actin protein. Figures 8 a and 9a show the experimental procedure in detail.
Statistical analysis
The locomotor activity data were analysed by a two-factor repeated-measures analysis of variance (ANOVA) with time as a repeated measure (drug treatmentrtime) (Figs 1, 6 ). Figures 3 and 4 and insets in Figs 1 and 6 show the data of total locomotor activity, which were tested by one-way ANOVA. In Fig. 2 , the total locomotor activity in morphinepretreated mice was relative to saline-pretreated mice (taken as 100 %) and an independent-sample t test was used to determine differences between groups. Twoway ANOVA and an independent-sample t tests were performed (Fig. 5) . In order to determine the relationship between acute (day 1) and subsequent (day 5) morphine effects on total locomotor activity, bivariate correlation (Pearson) was used [see insets of Fig. 1 (b, c) ].
In the RT-PCR array (Fig. 7 c) , the % change of gene expression was calculated as (X/C-1) 100 % where X is the 2 xDCt value of gene expression in different groups that were injected with morphine (5 mg/kg i.p.) and C is the 2 xDCt value of gene expression in the control group that was injected with saline during the challenge test (day 8). Positive genes were identified by (1) the significant alterations of gene expression levels after normalization to control group (Sal+Sal+Sal, taken as 0 %) are >30 % in response to morphineinduced locomotor sensitization and (2) can be reversed by both AD (12 mg/kg i.p.) and CHX (2 mg/ kg i.p.) corresponding with the inhibitory effects on the induction of locomotor sensitization to a single morphine exposure. In order to simplify the significance analysis of Hsp70 expression levels in Western blot, the relative optical densities on the immunoblot gels were normalized to the control (Sal+Sal, taken as 100 %). The normalized data in Figs 8 and 9 were analysed by one-way ANOVA. LSD test was performed for all posthoc comparisons. Results with p<0.05 were regarded as statistically significant.
Results
Dose-effect relationship in locomotor sensitization to a single morphine exposure in mice
In the first experiment, two-factor repeated-measures ANOVA demonstrated that acute treatment (treat) with morphine significantly induced hyperlocomotion on day 1 [F treat(4,74) =37.076, p=0.000 ; F time(11,814) = 11.756, p=0.000 ; F timertreat(44,814) =9.421, p=0.000] ( Fig. 1b) , indicating a dose-and time-dependent effect of acute morphine injection on locomotor activity. The inset of Fig. 1 b shows the effects of a series of morphine doses on total locomotor activity in mice. One-way ANOVA and post-hoc LSD test revealed that systemic administration of morphine (5, 10, 20, 40 mg/ kg i.p.) dose-dependently increased locomotor activity (F 4,74 =37.074, p<0.001).
In Fig. 1 c, all mice received a challenge injection of 5 mg/kg morphine after 4 d of drug withdrawal (on day 5). The main effect of morphine challenge was statistically significant [F treat(4,74) =3.123, p<0.05], but there was no significant interaction between morphine treatment and time of drug action [F timertreat(44,814) = 1.372, p>0.05] (Fig. 1 c) . One-way ANOVA was used to further analyse the differences of total locomotor activity between groups ( Fig. 1 c, inset) , indicating that locomotor sensitization could be observed in mice pretreated with 20 or 40 mg/kg morphine, but not in mice pretreated with 5 or 10 mg/kg morphine (F 4,74 =3.123, p<0.05). Moreover, the results from the analysis of bivariate correlation (Pearson) demonstrated that there was a significant correlation between locomotor activity on day 1 (Fig. 1 b, inset) and on day 5 (Fig. 1c, inset ) in response to morphine treatment (r=0.967, p=0.007, n=5). A pretreatment dose of 20 mg/kg of morphine was selected to induce locomotor sensitization in the following experiments.
Time-course of locomotor sensitization induced by a single morphine exposure in mice
To determine the time-course for the incubation of locomotor sensitization, we investigated whether locomotor sensitization to morphine challenge altered over time. Challenge test revealed different locomotor responses to morphine (5 mg/kg i.p.) in mice with a history of either saline or morphine (20 mg/kg i.p.) pretreatment after various post-treatment intervals. Compared to saline-pretreated mice, the locomotor activity in morphine-pretreated mice was elevated by 23.4 %, 14.4 %, 10.2 %, 71.8 %, 78.0 %, 50.5 %, and 67.0 % after 1, 2, 3, 4, 7, 14, 21 Figure 2b shows that the locomotor sensitization induced by a single injection of morphine (20 mg/kg i.p.) was observed 4 d after withdrawal, in agreement with the results previously shown in Fig. 1 c. The maximal sensitization effects of morphine in morphine-pretreated mice were observed 1 wk (day 8) after a single exposure to morphine (20 mg/kg i.p.). Fig. 6 , locomotor activity in the Sal+Mor group was substantially higher than in the Sal+Sal group (p<0.001), indicating locomotor sensitization to a single morphine exposure. Based on the schedule of drug administration (Fig. 6 a) , 1 wk after exposure, locomotor sensitization to a single pretreatment injection of morphine (20 mg/kg i.p.) was significantly suppressed, in mice challenged with 5 mg/kg morphine, by 6 and 12 mg/kg AD (Fig. 6 b) [F treat(3,60) =14.184, p=0.000 ; F time(11,660) =22.561, p= 0.000 ; F timertreat(33,660) =1.201, p=0.206] or by 1 and 2 mg/kg CHX (Fig. 6 c) [F treat(3,60) =23.099, p=0.000 ; F time(11,660) =18.875, p=0.000 ; F timertreat(33,660) =2.426, p=0.000]. Further, one-way ANOVA and post-hoc LSD test were performed on the data shown in the insets of Fig. 6 (b, c) , revealing that pretreatment with AD (6, 12 mg/kg i.p.) or CHX (1, 2 mg/kg i.p.) reduced total locomotor activity upon challenge with morphine (5 mg/kg) in a dose-dependent manner. These results suggest that AD and CHX can attenuate the induction of locomotor sensitization to a single morphine exposure in mice.
Changes of Hsp70 in the NAc of mice sensitized to a single morphine exposure (Fig. 7 b) . According to functional gene groupings, the array can be divided into several functional classes, which include eight genes containing serum response element (SRE) or SRE-like enhancer sequences, 63 genes containing the cAMP response element (CRE) enhancer sequence, nine genes containing other Ca 2+ responsive elements, and four genes containing both SRE and CRE enhancer sequences.
As shown in Fig. 7 c, we found that only two genes were associated with locomotor sensitization induced by a single morphine injection from 84 candidate genes in this array, including heat shock protein 4 (Hspa4 or Hsp70) and prostaglandin-endoperoxide synthase 2 (Ptgs2 or COX2). A single exposure to morphine (20 mg/kg i.p.) resulted in the upregulation of mRNA expression of Hsp70 (+59 %) and COX2 (+51 %) in the NAc of mice following challenge (Fig. 7 a) and locomotor experiments (Fig. 6 a) . One-way ANOVA demonstrated significant differences between groups (F 4,20 =3.164, p<0.05) (Fig. 9) . Moreover, our data clearly revealed that Hsp70 protein expression in morphine-sensitized mice (group 3) had a significant increase relative to that of the control group (group 1) and the acute morphine treatment group (group 2) by +26 % (p<0.05) and +23 % (p<0.05), respectively, whereas co-administration of morphine (20 mg/kg i.p.) with AD (12 mg/ kg i.p.) or CHX (2 mg/kg i.p.) attenuated Hsp70 protein expression in the NAc (group 4 vs. group 3 : p<0.05 ; group 5 vs. group 3 : p<0.01).
Discussion
Here we report that mice reliably show behavioural sensitization upon challenge following a single exposure to morphine. Moreover, this phenomenon is dependent upon the dose of morphine and is associated with de-novo protein synthesis, since the induction of sensitization can be reduced by AD or CHX. More importantly, this reduction may be independent of the proactive effects of AD or CHX on the induction of behavioural sensitization to a single morphine exposure. In terms of candidate proteins, the increased expression of Hsp70 gene and protein within the NAc was parallel to behavioural sensitization and similarly prevented by inhibition of new protein synthesis. To date, only one study has reported that a single exposure to morphine can produce behavioural sensitization in rats (Vanderschuren et al. 2001) . We extend these findings to mice, which following a single injection of morphine (20 and 40 mg/kg) showed an exaggerated behavioural response to morphine challenge compared to the control groups. Thus, behavioural sensitization induced by a single exposure to drug of abuse appears to be a property shared by various drugs of abuse like opiates and psychostimulants in both rats and mice (Kalivas & Alesdatter, 1993 ; Kim et al. 2004 ; Robinson et al. 1982 ; Vanderschuren et al. 1999) .
We examined the effects of a range of morphine doses from 5 to 40 mg/kg on locomotor activity (acute morphine effects) and sensitization (subsequent morphine effects) in mice. Our data indicated that lowdose morphine (5 and 10 mg/kg) could produce acute hyperlocomotion, but not induce subsequent locomotor sensitization. Further, a high correlation was found between acute hyperlocomotion and subsequent locomotor sensitization of morphine. With regard to behavioural sensitization, the pattern of effects induced by repeated intermittent exposure to morphine and psychostimulants resembles other forms of neural plasticity such as kindling, learning, and memory (Ito et al. 1997) . Taking this correlation into consideration, it is likely that the enduring consequences of a single morphine exposure may be associated in part with the process of neural adaptation analogous to that needed for learning and memory. Our previous studies have reported that repeated intermittent treatment with morphine (10 mg/ kg) leads to behavioural sensitization (Li et al. 2004 a, b ; Zhang et al. 2003) ; however, a single exposure of this dose of morphine failed to demonstrate such effects in mice. Here we show that sensitization occurs to a single treatment of morphine at doses >20 mg/kg.
Behavioural sensitization is generally considered to be the result of the functional translation of neural adaptation into psychocomotor responses (Pierce & Kalivas, 1997) . Incubation of behavioural sensitization after pretreatment with addictive drugs has been implicated in the process of establishing sensitization (King et al. 2000 ; Liang & Han, 2004) . There is evidence that maximal effects of behavioural sensitization are not observed immediately after the last exposure, but rather some time after discontinuing the drug administration paradigm (Post, 1980) . Vanderschuren et al. (1999) reported the effects of behavioural sensitization to a single amphetamine injection are dependent on time interval after pretreatment in rats. In the present study, we investigated the effects of a wide range of time intervals after a single exposure to morphine (20 mg/kg) on the intensity of locomotor sensitization in mice. Our results indicated that at least 4 d of drug washout following a single morphine injection appear to be required to produce a clear manifestation of locomotor sensitization to morphine challenge in mice, suggesting that there indeed exists a time-window for incubating behavioural sensitization from its initiation (pharmacological stimulation) to expression (the enduring consequences). Interestingly, however, in contrast to the time-dependent increase in behavioural sensitization to amphetamine in rats reported by Vanderschuren et al. (1999) , there was no correlation between the magnitude of behavioural sensitization and the duration of drug washout in morphineexposed mice, under the present experimental design. A number of studies have shown that behavioural sensitization is long-lasting, persisting for weeks, months, and even 1 yr in rats and mice (Kalivas & Stewart, 1991 ; Paulson et al. 1991 ; Pierce & Kalivas, 1997) . This notion is supported by the present study, in which mice sensitized to a single morphine injection still expressed sensitized behaviour upon challenge with morphine after a 21-d drug washout. In conclusion, behavioural sensitization induced by a single morphine exposure in mice is a useful model to study long-lasting neural adaptation and plasticity. Electrophysiologically, long-term potentiation and long-term depression are commonly considered as models for investigation of cellular aspects of learning, memory and neuroplasticity (Kim & Linden, 2007 ; Malenka & Bear, 2004) . Previous studies have demonstrated that a single exposure to cocaine can enhance glutamatergic synaptic transmission in the mesolimbic dopamine system (Argilli et al. 2008 ; Borgland et al. 2004 ; Ungless et al. 2001) . Moreover, protein synthesis inhibitors and mRNA translation inhibitors can prevent cocaine-induced alteration of the AMPA receptor/NMDA receptor ratio (Argilli et al. 2008) , strongly implicating gene transcription and protein synthesis for synaptic plasticity in the mesolimbic dopamine circuit as a mechanism that may pertain to behavioural sensitization. Behaviourally, we found that the transcription inhibitor AD or the protein synthesis inhibitor CHX could dose-dependently block the induction of behavioural sensitization to a single morphine exposure in mice. In support of our results, previously reported data have indicated that induction of behavioural sensitization to amphetamine and cocaine can be blocked by protein synthesis inhibitors such as CHX and anisomycin in mice and rats (Karler et al. 1993 ; Sorg & Ulibarri, 1995 ; Valjent et al. 2006) . Our results confirm and extend the fact that de-novo protein synthesis is apparently involved in the mechanism underlying the induction of behavioural sensitization following a single exposure to morphine, analogous to the acquisition process of memory following learning (Inda et al. 2005 ; Kandel, 2001 ; Valjent et al. 2006) .
It is important to note that the induction of behavioural sensitization appears to be a labile short-term state involving a protein synthesis-dependent stabilizing process. Data from our previous studies have demonstrated that L-type Ca 2+ channel blockers (nimodipine, nifedipine, verapamil), valproate (GABA transaminase inhibitor), and 5-HTP (a precursor of serotonin) could prevent the induction, but not the expression, of sensitization induced by repeated intermittent treatment with morphine in mice (Li et al. 2004a (Li et al. , 2008 Zhang et al. 2003) . Therefore, the induction of behavioural sensitization may be vulnerable to disruption by co-administering morphine with other drugs during the sensitizing period.
Long-lasting effects of a single morphine injection are probably mediated through altering gene expression in the CNS (Nestler, 2001a) . Characterization of these genes should help clarify the molecular mechanisms underlying behavioural sensitization to a single morphine exposure. The NAc is a region implicated in the mechanisms underlying the acquisition and expression of drug-related behaviours (Hyman & Malenka, 2001 ; Valjent et al. 2006) . Therefore, we used an RT-PCR array to analyse the expression of 84 genes relevant to cAMP/Ca 2+ signalling pathway in the NAc of mice sensitized to a single morphine injection. Surprisingly, only two genes Hsp70 and COX2 had their expression altered in association with the induction of behavioural sensitization to a single morphine injection in mice. The antagonism of both AD and CHX against the alteration of Hsp70 and COX2 mRNA by the challenge with morphine may suggest a protein/RNA synthesis-dependent mechanism for the regulation of Hsp70 and COX2 mRNA levels in the NAc of mice sensitized by a single morphine injection. Few studies have been performed to explore a role of COX2 in morphine dependence, so Hsp70 was selected for subsequent Western blot analysis. The results confirmed that the increase in Hsp70 gene expression is translated into elevated Hsp70 protein expression, which can also be antagonized by AD or CHX. Evidently, the possible effect of multiple exposures to AD or CHX (i.p. once daily for 3 d) on Hsp70 protein expression can be excluded. Moreover, the challenge with morphine (5 mg/kg i.p.) fails to alter the level of Hsp70 protein expression in NAc of mice. These findings suggest that induction of Hsp70 in NAc may run parallel with induction of behavioural sensitization to a single morphine exposure in mice. Hsp70 is postulated to be a stress-induced protein involving protective adaptation that spares cells from the damage caused by heat, toxins, infection, seizure, trauma, ischaemia, or other cellular stresses and facilitates cellular recovery (Arya et al. 2007 ; Morimoto & Santoro, 1998) . Similarly, it is reported that pretreatment with microinjection of AD or CHX can block lipopolysaccharide-induced up-regulation of Hsp70 expression in the ventrolateral medulla of rats (Li et al. 2005) . In general, an induction of Hsp70 after morphine injection is attributed to stress responses to potentially cytotoxic effects of morphine in several brain regions of rats (Ammon-Treiber et al. 2004 ; Ammon-Treiber & Hollt, 2005) . However, this is somewhat controversial as some investigations have reported that morphine can produce cytotoxicity to cause apoptosis, whereas other studies have shown that morphine has protective effects against cell death Zhang et al. 2008) . Morphine-induced Hsp70 expression, therefore, may or may not relate to 'stress ' responses to morphine. Due to a relatively low dose, a single injection, and the long interval in this study, the delayed changes in Hsp70 expression after a single morphine injection may not relate to cytotoxicity. As a protein molecule underlying cellular protective mechanisms, Hsp70 may play a functional role in the neural plasticity associated with addicting drugs. It is intriguing to note that the fact that Hsp70 expression in the NAc induced by a single morphine exposure was blocked by the transcription inhibitor AD or the protein synthesis inhibitor CHX in mice in this study and by the opioid receptor antagonist naloxone in rats (Ammon-Treiber et al. 2004) would imply a mechanism that either directly or indirectly involves opioid receptors.
The present findings should be explained with caution to preclude the non-specific effects of AD and CHX. It is well known that large doses of the transcription and protein synthesis inhibitors have some side-effects such as diarrhoea, decreased food and water intake, body weight loss and locomotor stimulation (Davis et al. 1980 ; Davis & Squire, 1984) . In the present study, the low doses of AD (6 and 12 mg/kg i.p.) and CHX (1 and 2 mg/kg i.p.) used alone did not produce obvious signs of toxicity or alter locomotor activity, which is supported by other reports (Capasso et al. 1996 ; Shimosato & Saito, 1993) . Therefore, the interference exerted by dopamine or CHX on morphine-induced hyperactivity and locomotor sensitization appears not to be associated with toxic, nonspecific side-effects. In addition, high doses such as 120 mg/kg CHX can inhibit dopamine and norepinephrine synthesis in the mouse brain (Flexner & Goodman, 1975) , whereas a single dose of 0.5-0.6 mg/ kg reduces brain protein synthesis by about 75 % (Pavlik & Teisinger, 1980 ; Snider et al. 2001) . In this study, CHX was administered 30 min before morphine injection. It is evident that CHX markedly reduces catecholamine synthesis several hours later (Bloom et al. 1977 ; Davis & Squire, 1984 ; Davis et al. 1980 ; Squire et al. 1976 ), but inhibits protein synthesis within 20 min after treatment (Pavlik & Teisinger 1980 ; Snider et al. 2001) . Thus, a temporal relationship between locomotor response and effects of CHX on protein and catecholamine synthesis should be considered. Actually, AD and CHX have distinct mechanisms of protein synthesis inhibition. AD is thought to act via intercalation with DNA, resulting in inhibition of RNA transcription and, secondarily, protein synthesis (Sobell & Jain, 1972) . In contrast, CHX inhibits protein synthesis by blocking the translation of messenger RNA on 80S ribosomes (Suzuki et al. 1992) . However, AD can produce the same the suppression of hyperactivity and locomotor sensitization induced by a single morphine exposure as CHX in mice. Taken together, the inhibitory effects of AD and CHX on protein synthesis appear to be associated with preventing hyperactivity and the induction of behavioural sensitization from a single exposure to morphine in mice.
In summary, our study demonstrates that persistent behavioural sensitization to morphine is established in mice after a single previous exposure. This induction of behavioural sensitization appears to be labile and protein synthesis-dependent. Our data provide the first evidence that an induction of Hsp70 expression in the NAc of mice may be involved in the induction of behavioural sensitization to a single morphine exposure.
